NO2498792T3 - - Google Patents

Info

Publication number
NO2498792T3
NO2498792T3 NO10830669A NO10830669A NO2498792T3 NO 2498792 T3 NO2498792 T3 NO 2498792T3 NO 10830669 A NO10830669 A NO 10830669A NO 10830669 A NO10830669 A NO 10830669A NO 2498792 T3 NO2498792 T3 NO 2498792T3
Authority
NO
Norway
Application number
NO10830669A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43992011&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2498792(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2498792T3 publication Critical patent/NO2498792T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Anesthesiology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO10830669A 2009-11-11 2010-11-10 NO2498792T3 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26030909P 2009-11-11 2009-11-11
PCT/US2010/056255 WO2011060083A1 (en) 2009-11-11 2010-11-10 Methods and compositions for rapid treatment of otitis externa

Publications (1)

Publication Number Publication Date
NO2498792T3 true NO2498792T3 (ko) 2017-12-30

Family

ID=43992011

Family Applications (1)

Application Number Title Priority Date Filing Date
NO10830669A NO2498792T3 (ko) 2009-11-11 2010-11-10

Country Status (28)

Country Link
US (1) US8927006B2 (ko)
EP (1) EP2498792B1 (ko)
JP (2) JP2013510861A (ko)
KR (2) KR20120116398A (ko)
CN (1) CN102612372B (ko)
AU (1) AU2010319538B2 (ko)
BR (1) BR112012011017A2 (ko)
CA (1) CA2780160C (ko)
CL (1) CL2012001227A1 (ko)
CO (1) CO6540004A2 (ko)
DK (1) DK2498792T3 (ko)
EC (1) ECSP12011967A (ko)
ES (1) ES2645200T3 (ko)
HR (1) HRP20171520T1 (ko)
HU (1) HUE034617T2 (ko)
IL (1) IL219483A (ko)
LT (1) LT2498792T (ko)
MX (1) MX2012005521A (ko)
MY (1) MY162687A (ko)
NO (1) NO2498792T3 (ko)
NZ (1) NZ599559A (ko)
PL (1) PL2498792T3 (ko)
PT (1) PT2498792T (ko)
RU (1) RU2680137C2 (ko)
SI (1) SI2498792T1 (ko)
UA (1) UA111147C2 (ko)
WO (1) WO2011060083A1 (ko)
ZA (1) ZA201203239B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036165A1 (en) * 2012-08-29 2014-03-06 Bayer Healthcare, Llc Aqueous based compositions for treating otitis externa
CN104337952A (zh) * 2013-08-10 2015-02-11 李谊 一种中西医结合治疗爆震性耳聋的组合药物
CN104739768A (zh) * 2013-12-27 2015-07-01 河南惠通天下生物工程有限公司 一种甲砜霉素纳米脂质体及其制备方法
MX2020005056A (es) * 2017-11-14 2020-10-28 Profem Gmbh Emulsiones para el tratamiento tópico de infecciones dérmicas y de mucosas.
EP3482744A1 (de) * 2017-11-14 2019-05-15 ProFem GmbH Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen
CN118512401A (zh) 2019-09-23 2024-08-20 迪迪艾斯研究公司 具有渗透促进剂的脂质囊泡组合物
US11986483B2 (en) * 2019-10-11 2024-05-21 Dechra Veterinary Products, Llc Otic formulations, methods and devices
CN113876658B (zh) * 2021-11-01 2023-10-20 仙乐健康科技股份有限公司 水包油型乳液组合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69528355T2 (de) * 1994-02-04 2003-05-15 Lipocore Holding Ab Stockholm Doppelschicht-zusammensetzungen aus digalactosyldiacylglycerol enthaltendem galactolipid
CA2201134A1 (en) * 1994-10-10 1996-04-18 Alfred Sallmann Ophthalmic and aural compositions containing diclofenac potassium
PT782448E (pt) * 1995-06-06 2002-07-31 Bayer Ag Formulacoes oticas antibacterianas nao ototoxicas nao sensibilizantes nao irritantes
IT1295369B1 (it) 1997-10-21 1999-05-12 Fatro Spa Composizione a base di tiamfenicolo e diclofenac
US6433024B1 (en) * 2000-05-08 2002-08-13 Karl F. Popp Topical anti-acne composition
AUPR798901A0 (en) * 2001-09-28 2001-10-25 Medvet Science Pty. Ltd. Spheroidal hdl particles with a defined phospholipid composition
US20080206161A1 (en) 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20050013854A1 (en) * 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
EP1651210A1 (en) 2003-07-31 2006-05-03 Pharmacia & Upjohn Company LLC Dispersible formulation of an anti-inflammatory agent
US20050159369A1 (en) 2003-08-20 2005-07-21 Qtm Llc Method of treatment of otitis externa
US20070078116A1 (en) 2003-08-20 2007-04-05 Fairfield Clinical Trials, Llc Method of treatment of otitis externa
US20070054844A1 (en) 2003-08-20 2007-03-08 Fairfield Clinical Trials, Llc Method for treating otitis externa
EP1784164A4 (en) 2004-09-03 2008-07-09 Piedmont Pharmaceuticals Llc PROCESS FOR TRANSMEMBRANE TREATMENT AND PREVENTION OF OTITIS MEDIA
EP1858506A2 (en) 2005-03-10 2007-11-28 3M Innovative Properties Company Methods of treating ear infections
US20090082337A1 (en) * 2007-09-21 2009-03-26 Srini Venkastesh Compositions Comprising Quinolone and Methods for Treating or Controlling Infections
US20090111780A1 (en) * 2007-10-31 2009-04-30 Everett Laboratories, Inc. Compositions and methods for treatment of ear canal infection and inflammation

Also Published As

Publication number Publication date
ECSP12011967A (es) 2012-08-31
UA111147C2 (uk) 2016-04-11
LT2498792T (lt) 2017-10-25
KR20120116398A (ko) 2012-10-22
NZ599559A (en) 2014-08-29
MX2012005521A (es) 2012-06-19
EP2498792B1 (en) 2017-08-02
US20110281809A1 (en) 2011-11-17
HRP20171520T1 (hr) 2017-11-17
DK2498792T3 (da) 2017-11-06
PL2498792T3 (pl) 2018-01-31
CA2780160C (en) 2018-03-06
EP2498792A1 (en) 2012-09-19
HUE034617T2 (en) 2018-02-28
CO6540004A2 (es) 2012-10-16
MY162687A (en) 2017-07-14
RU2012124067A (ru) 2013-12-20
PT2498792T (pt) 2017-10-18
AU2010319538A1 (en) 2012-05-17
CN102612372A (zh) 2012-07-25
SI2498792T1 (sl) 2017-11-30
BR112012011017A2 (pt) 2015-09-15
US8927006B2 (en) 2015-01-06
CL2012001227A1 (es) 2012-08-24
ES2645200T3 (es) 2017-12-04
WO2011060083A1 (en) 2011-05-19
KR20170100680A (ko) 2017-09-04
JP2016102112A (ja) 2016-06-02
RU2680137C2 (ru) 2019-02-18
CN102612372B (zh) 2016-01-20
AU2010319538B2 (en) 2015-04-09
ZA201203239B (en) 2013-07-31
JP2013510861A (ja) 2013-03-28
IL219483A0 (en) 2012-06-28
EP2498792A4 (en) 2013-06-12
IL219483A (en) 2017-12-31
KR101901083B1 (ko) 2018-09-20
CA2780160A1 (en) 2011-05-19
JP6138891B2 (ja) 2017-05-31

Similar Documents

Publication Publication Date Title
BE2015C040I2 (ko)
BR112012012396A2 (ko)
BR112012000607A2 (ko)
BRPI0925311A2 (ko)
BRPI0924307A2 (ko)
BR122021004633A2 (ko)
BR122017024704A2 (ko)
BR112012012487A2 (ko)
BR112012000665A2 (ko)
BR112012009797A2 (ko)
BR112012012080A2 (ko)
BR112012009446A2 (ko)
BR112012009703A2 (ko)
BR112012010357A2 (ko)
BR112012007656A2 (ko)
BR122019005883A2 (ko)
BR112012000159A2 (ko)
BRPI0924534A2 (ko)
BR112012014856A2 (ko)
BR112012000255A2 (ko)
BR122017013721A2 (ko)
BR112012000156A2 (ko)
BRPI0924617A2 (ko)
BRPI0925022A2 (ko)
BR112012016234A2 (ko)